新型冠状病毒

Countries across Europe suspend use of Oxford-AstraZeneca jab

WHO urges authorities not to pause vaccinations despite blood clot fears as UK stands by approval

Countries across Europe have suspended the Oxford/AstraZeneca Covid-19 vaccine over concerns the jab may cause blood clots, even though medicines regulators and the World Health Organization say there is no evidence of problems.

Germany, Italy, France, Spain and the Netherlands became the latest countries to pause the rollout of the jab on Monday. Norway, Denmark and Bulgaria suspended their programmes last week.

The suspensions came as the WHO urged nations not to pause Oxford/AstraZeneca inoculation programmes, having said last week there was no sign the problems had been caused by the jab. Boris Johnson, the UK prime minister, said Britain’s medicines regulator saw “no reason to discontinue” use of the vaccine, with Downing Street asserting that the jab was both “safe and effective”.

您已阅读16%(795字),剩余84%(4302字)包含更多重要信息,订阅以继续探索完整内容,并享受更多专属服务。
版权声明:本文版权归manbetx20客户端下载 所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。
设置字号×
最小
较小
默认
较大
最大
分享×